SEHK:6938Biotechs
Suzhou Ribo Life Science (SEHK:6938) Stock Rallies On Revenue Burst As Losses Linger
Suzhou Ribo Life Science stock has been on a tear, with a 30‑day gain of about 33%, but today’s H1 2026 earnings remind you why the story is still high risk. The headline is a powerful revenue surge to ¥419.7m in the half, yet on a trailing twelve month view the business remains loss making with earnings from continuing operations at a loss of ¥167.2m. The short term excitement sits against a longer term question: can this revenue engine eventually cover the ongoing burn that comes with a...